Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof

Details for Australian Patent Application No. 2008314569 (hide)

Owner Kinex Pharmaceuticals, LLC

Inventors Hangauer, David G.

Agent Cullens

Pub. Number AU-A-2008314569

PCT Pub. Number WO2009/051848

Priority 60/999,943 20.10.07 US

Filing date 20 October 2008

Wipo publication date 23 April 2009

International Classifications

A61K 31/216 (2006.01)

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 31/5377 (2006.01)

C07D 213/55 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/051848 Priority application(s): WO2009/051848

8 July 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 13 May 2010

9 September 2010 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Hangauer, David G. Jr.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008314573-Methods and apparatus to create a media measurement reference database from a plurality of distributed sources

2008314567-Translocation and mutant ROS kinase in human non-small cell lung carcinoma